Literature DB >> 27191365

Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study.

Oreste Marrone1, Salvatore Battaglia2, Paschalis Steiropoulos3, Ozen K Basoglu4, John A Kvamme5, Silke Ryan6,7, Jean-Louis Pepin8, Johan Verbraecken9, Ludger Grote10, Jan Hedner10, Maria R Bonsignore1,2.   

Abstract

The cross-sectional relationship of obstructive sleep apnea with moderate to severe chronic kidney disease, defined as an estimated glomerular filtration rate <60 mL min-1 ∙1.73 m-2 , was investigated in a large cohort of patients with suspected obstructive sleep apnea studied by nocturnal polysomnography or cardiorespiratory polygraphy. Data were obtained from the European Sleep Apnea Database, where information from unselected adult patients with suspected obstructive sleep apnea afferent to 26 European sleep centres had been prospectively collected. Both the Modification of Diet in Renal Disease and the Chronic Kidney Disease-Epidemiology Collaboration equations were used for the assessment of estimated glomerular filtration rate. The analysed sample included 7700 subjects, 71% male, aged 51.9 ± 12.5 years. Severe obstructive sleep apnea (apnea-hypopnea index ≥30) was found in 34% of subjects. The lowest nocturnal oxygen saturation was 81 ± 10.2%. Chronic kidney disease prevalence in the whole sample was 8.7% or 6.1%, according to the Modification of Diet in Renal Disease or the Chronic Kidney Disease-Epidemiology Collaboration equations, respectively. Subjects with lower estimated glomerular filtration rate were older, more obese, more often female, had worse obstructive sleep apnea and more co-morbidities (P < 0.001, each). With both equations, independent predictors of estimated glomerular filtration rate <60 were: chronic heart failure; female gender; systemic hypertension; older age; higher body mass index; and worse lowest nocturnal oxygen saturation. It was concluded that in obstructive sleep apnea, chronic kidney disease is largely predicted by co-morbidities and anthropometric characteristics. In addition, severe nocturnal hypoxaemia, even for only a small part of the night, may play an important role as a risk factor for kidney dysfunction.
© 2016 European Sleep Research Society.

Entities:  

Keywords:  epidemiology; hypoxia; nephropathy

Mesh:

Substances:

Year:  2016        PMID: 27191365     DOI: 10.1111/jsr.12426

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  18 in total

1.  Serum levels of NGAL and cystatin C as markers of early kidney dysfunction in patients with obstructive sleep apnea syndrome.

Authors:  Athanasios Voulgaris; Kostas Archontogeorgis; Evangelia Nena; Christina Tsigalou; Maria Xanthoudaki; Maria Kouratzi; Grigorios Tripsianis; Marios Froudarakis; Paschalis Steiropoulos
Journal:  Sleep Breath       Date:  2018-06-26       Impact factor: 2.816

2.  Obstructive sleep apnea and chronic kidney disease: open questions on a potential public health problem.

Authors:  Oreste Marrone; Maria R Bonsignore
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

3.  Burden of Nocturnal Hypoxia and Type of Positive Airway Pressure Therapy May Influence Markers of Acute Kidney Injury in Patients With Obstructive Sleep Apnea.

Authors:  Athanasios Voulgaris; Evangelia Nena; Paschalis Steiropoulos
Journal:  J Clin Sleep Med       Date:  2019-11-15       Impact factor: 4.062

4.  Rationale and Design of the Turkish Sleep Apnea Database - TURKAPNE: A National, Multicenter, Observational, Prospective Cohort Study.

Authors:  Yüksel Peker; Özen K Başoğlu; Hikmet Fırat
Journal:  Turk Thorac J       Date:  2018-07-01

5.  Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome.

Authors:  Kostas Archontogeorgis; Evangelia Nena; Christina Tsigalou; Athanasios Voulgaris; Maria Xanthoudaki; Marios Froudarakis; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2016-10-24

6.  Comparison of clinical scores in their ability to detect hypoxemic severe OSA patients.

Authors:  Eric Deflandre; Nicolas Piette; Vincent Bonhomme; Stephanie Degey; Laurent Cambron; Robert Poirrier; Jean-Francois Brichant; Jean Joris
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

Review 7.  Mechanisms of cognitive dysfunction in CKD.

Authors:  Davide Viggiano; Carsten A Wagner; Gianvito Martino; Maiken Nedergaard; Carmine Zoccali; Robert Unwin; Giovambattista Capasso
Journal:  Nat Rev Nephrol       Date:  2020-03-31       Impact factor: 28.314

8.  Comparison of Jaw Elevation Device vs. Conventional Airway Assist during Sedation in Chronic Kidney Diseases Undergoing Arteriovenous Fistula Surgery: A Randomized Controlled Trial.

Authors:  Sang Hyun Lee; Ji Seon Jeong; Jaeni Jang; Young Hee Shin; Nam-Su Gil; Ji-Won Choi; Tae Soo Hahm
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

9.  Insulin Sensitivity and Insulin Resistance in Non-Diabetic Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome.

Authors:  K Archontogeorgis; N Papanas; E Nena; A Tzouvelekis; C Tsigalou; A Voulgaris; M Xanthoudaki; T Mouemin; M Froudarakis; P Steiropoulos
Journal:  Open Cardiovasc Med J       Date:  2017-12-29

10.  SAS score: Targeting high-specificity for efficient population-wide monitoring of obstructive sleep apnea.

Authors:  Alexandru Topîrceanu; Mihai Udrescu; Lucreţia Udrescu; Carmen Ardelean; Rodica Dan; Daniela Reisz; Stefan Mihaicuta
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.